Ahmet Acar, CEO and Founder at HistoCan, shared on LinkedIn:
“Very happy to share our latest paper, where we discuss the role of matrix stiffness in overcoming drug resistance in cancer.
The study, led by our talented graduate student Hakan Berk Aydin, showcases another successful collaboration with Altug Ozcelikkale from the Department of Mechanical Engineering.”
Source: Ahmet Acar/LinkedIn